Beauty Health Company (The) designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems. The company also provides HydraFacial CONNECT platform, a three-level industry certification program that will advance aesthetic professionals' skills and give them recognition, respect, and rewards; and system surgical smoke evacuators that vacuums the plume created by laser and electrocautery treatments, such as hair removal, tattoo removal, erbium, and veterinary procedures. Its system surgical smoke evacuators are used by hospitals, plastic surgeons, cosmetic surgeons, OB/GYN, veterinarians, and others. In addition, it offers marketing support services. Its products are distributed worldwide through its sales network. The company was founded in 1997 and is based in Signal Hill, California with a location in Long Beach, California.
| Market Cap | 1.798 Billion | Shares Outstanding | 150.598 Million | Avg 30-day Volume | 2.757 Million |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.63 |
| Price to Revenue | 3.3587 | Debt to Equity | -7.2275 | EBITDA | -1.196 Million |
| Price to Book Value | 0.0 | Operating Margin | -14.427499999999998 | Enterprise Value | 607.05 Million |
| Current Ratio | 1.911 | EPS Growth | -16 | Quick Ratio | 0.907 |
| 1 Yr BETA | 2.185 | 52-week High/Low | 30.17 / 9.95 | Profit Margin | -24.4979 |
| Operating Cash Flow Growth | -819.6759 | Altman Z-Score | 1.1067 | Free Cash Flow to Firm | -189.117 Million |
| Earnings Report | 2022-08-09 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
WATSON DANIEL COPELL EXECUTIVE VP AMERICAS SALES |
|
187,500 | 2022-04-28 | 5 |
|
STANLEICK ANDREW ROY CHIEF EXECUTIVE OFFICER |
|
0 | 2022-02-07 | 2 |
|
8,554,667 | 2022-02-04 | 3 | |
|
WOO LIYUAN CHIEF FINANCIAL OFFICER |
|
452,968 | 2022-02-04 | 5 |
|
PAMAMULL INDRA PRESIDENT, APAC |
|
66,716 | 2022-02-04 | 4 |
|
BECKER STEPHAN PRESIDENT, EMEA |
|
55,596 | 2022-02-04 | 3 |
|
5,160 | 2021-09-10 | 1 | |
|
5,160 | 2021-09-10 | 1 | |
|
5,160 | 2021-09-10 | 1 | |
|
29,353 | 2021-09-10 | 2 | |
|
5,160 | 2021-09-10 | 1 | |
|
5,160 | 2021-09-10 | 1 | |
|
CARNELL CLINTON E. CHIEF EXECUTIVE OFFICER |
|
50,000 | 2021-09-10 | 4 |
|
LINDEN CAPITAL PARTNERS III LP |
|
36,568,002 | 2021-08-25 | 3 |
|
9,333,333 | 2020-10-02 | 3 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-02 17:27:03 -0400 | 2022-04-28 | A | 187,500 | a | 187,500 | direct |
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| BEAUTY HEALTH CO-THE SKIN | 2022-05-16 16:15:03 UTC | -0.7464 | 1.5664 | 1500000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-16 15:45:03 UTC | -0.7464 | 1.5664 | 1500000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-16 15:15:03 UTC | -0.7464 | 1.5664 | 1500000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-16 14:45:03 UTC | -0.7464 | 1.5664 | 1500000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-16 14:15:03 UTC | -0.7464 | 1.5664 | 1500000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-16 13:45:04 UTC | -0.7464 | 1.5664 | 1500000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-16 13:15:03 UTC | -0.7464 | 1.5664 | 1500000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-16 12:45:04 UTC | -0.7464 | 1.5664 | 1500000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 22:15:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 21:45:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 21:15:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 20:45:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 20:15:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 19:45:04 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 19:15:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 18:45:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 18:15:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 17:45:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 17:15:03 UTC | -0.7464 | 1.5664 | 1200000 |
| BEAUTY HEALTH CO-THE SKIN | 2022-05-13 16:45:03 UTC | -0.7464 | 1.5664 | 1200000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|---|---|---|---|
| THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio | SKIN | -8185.0 shares, $-197749.6 | 2021-12-31 | N-PORT |
| JNL Series Trust- JNL Multi-Manager Alternative Fund | SKIN | -31092.0 shares, $-751182.72 | 2021-12-31 | N-PORT |
| Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | SKIN | -200.0 shares, $-4832.0 | 2021-12-31 | N-PORT |
| Morningstar Funds Trust- Morningstar Alternatives Fund | SKIN | -13408.0 shares, $-190393.6 | 2022-01-31 | N-PORT |
| Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund | SKIN | -32034.0 shares, $-620818.92 | 2022-02-28 | N-PORT |
| INVESTMENT MANAGERS SERIES TRUST- 361 Domestic Long/Short Equity Fund | SKIN | -1993.0 shares, $-28300.6 | 2022-01-31 | N-PORT |
| Calamos Investment Trust/IL- Calamos Market Neutral Income Fund | SKIN | -173100.0 shares, $-2458020.0 | 2022-01-31 | N-PORT |
